
Biointron is pleased to announce our participation in the 17th World ADC San Diego, taking place October 12–15, 2026, in San Diego, California.
World ADC San Diego is one of the largest and longest-standing global forums dedicated to antibody-drug conjugates and the broader bioconjugate field. The program is designed to address ADC development from discovery through manufacturing, with seven dedicated content streams spanning discovery chemistry, discovery biology, preclinical development, translational medicine, clinical lessons, process and analytical development, and manufacturing and supply.
As ADC pipelines become more competitive and technically sophisticated, high-quality antibody generation, expression, characterization, and developability assessment remain critical to selecting candidates with the right targeting, internalization, and manufacturability profiles. World ADC San Diego provides a valuable setting for Biointron to engage with teams advancing next-generation ADCs, bispecific ADCs, DACs, ISACs, AOCs, and other emerging conjugate formats.
Biointron looks forward to connecting with ADC innovators, collaborators, and industry partners in San Diego and joining conversations that support the continued advancement of antibody-based conjugate therapeutics.
For more details about the event, please visit the World ADC San Diego 2026 website [https://worldadc-usa.com/]
Time: October 12 - 15, 2026
Location: Town & Country Resort | San Diego, CA
Booth: TBD
Biointron is excited to share that we will be attending BIO KOREA 2026, taking p……
Biointron is proud to announce our attendance at the AACR Annual Meeting 2026, t……
Biointron is excited to announce our participation in Immunology 2026, the 109th……
Biointron is pleased to announce that we will be attending the Antibody Therapeu……